MDMA and Performance under a Progressive-Ratio Schedule of Water Delivery

Experimental and Clinical Psychopharmacology

Volumn 11, Issue 4, 2003, Pages 309-316

  Laraway, Sean ^a   Snycerski, Susan ^a   Poling, Alan ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; WATER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; NONHUMAN; RAT; REINFORCEMENT; WATER DEPRIVATION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MALE; MOTIVATION; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; WATER DEPRIVATION;

EID: 0242637194     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.11.4.309     Document Type: Article

References (59)

1. Baron, A., Mikorski, J., & Schlund, M. (1992). Reinforcement magnitude and pausing on progressive-ratio schedules. Journal of the Experimental Analysis of Behavior, 58, 377-388.
2. Bilsky, E. J., Hui, Y., Hubbell, C. L., & Reid, L. D. (1990). Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage. Pharmacology Biochemistry and Behavior, 37, 633-638.
3. Byrne, T., Baker, L. E., & Poling, A. (2000). MDMA and learning: Effects of acute and neurotoxic exposure in the rat. Pharmacology Biochemistry and Behavior, 66, 501-508.
4. Callaway, C. W., Wing, L. L., & Geyer, M. A. (1990). Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. Journal of Pharmacology and Experimental Therapeutics, 254, 456-464.
5. Cherney, D. Z., Davids, M. R., & Halperin, M. L. (2002). Acute hyponatraemia and 'ecstasy': Insights from a quantitative and integrative analysis. QJM: Monthly Journal of the Association of Physicians, 95, 475-483.
6. de Villiers, P. (1977). Choice in concurrent schedules and a quantitative formulation of the law of effect. In W. K. Honig & J. E. R. Staddon (Eds.), Handbook of operant behavior (pp. 233-287). Englewood Cliffs, NJ: Prentice Hall.
7. Fantegrossi, W. E., Ullrich, T., Rice, K. C., Woods, J. H., & Winger, G. (2002). 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: Serotonergic involvement. Psychopharmacology, 161, 356-364.
8. Frederick, D. L., Gillam, M. P., Allen, R. R., & Paule, M. G. (1995). Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys. Pharmacology Biochemistry and Behavior, 51, 301-307.
9. Glennon, R. A., Little, P. J., Rosencrans, J. A., & Yousif, M. (1987). The effects of MDMA ("ecstasy") and its optical isomers on schedule-controlled responding in mice. Pharmacology Biochemistry and Behavior, 26, 425-426.
10. Glennon, R. A., & Young, R. (1984). Further investigation of the discriminative stimulus properties of MDA. Pharmacology Biochemistry and Behavior, 20, 501-505.
11. Gordon, C. J., Watkinson, W. P., O'Callaghan, J. P., & Miller, D. B. (1991). Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacology Biochemistry and Behavior, 38, 339-344.
12. Gosnell, B. A., Levine, A. S., & Morley, J. E. (1986). The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sciences, 38, 1081-1088.
13. Gowing, L. R., Henry-Edwards, S. M., Irvine, R. J., & Ali, R. G. (2002). The health effects of ecstasy: A literature review. Drug and Alcohol Review, 21, 53-63.
14. Green, A. R., Cross, A. J., & Goodwin, G. M. (1995). Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacology, 119, 247-260.
15. Gulati, K., Ray, A., & Sharma, K. K. (1991). Effects of acute and chronic morphine on food intake in rats: Modulation by oxytocin and vasopressin. Pharmacology Biochemistry and Behavior, 40, 27-32.
16. Hartung, T. K., Schofield, E., Short, A. I., Parr, M. J., & Henry, J. A. (2002). Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") ingestion. QJM: Monthly Journal of the Association of Physicians, 95, 431-437.
17. Hodos, W. (1961, September 25). Progressive ratio as a measure of reward strength. Science, 134, 943-944.
18. Hodos, W., & Kalman, G. (1963). Effects of increment size and reinforcer volume on progressive ratio performance. Journal of the Experimental Analysis of Behavior, 6, 387-392.
19. Huitema, B. E. (1980). The analysis of covariance and alternatives. New York: Wiley.
20. Jarema, K., Macomber, C., LeSage, M., & Poling, A. (1999). Acute and chronic effects of morphine under a progressive-ratio 25 schedule of food delivery. Pharmacology Biochemistry and Behavior, 62, 209-214.
21. Jones, C. A., LeSage, M., Sundby, S., & Poling, A. (1995). Effects of cocaine in pigeons responding under a progressive-ratio schedule of food delivery. Pharmacology Biochemistry and Behavior, 50, 527-531.
22. Jones, J. R., & Caul, W. F. (1989). Time course of the effect of amphetamine on eating is biphasic. Behavioral Neuroscience, 103, 1047-1052.
23. Katz, J. L. (1990). Models of relative reinforcing efficacy of drugs and their predictive utility. Behavioural Pharmacology, 1, 283-301.
24. Lamb, R. J., & Griffiths, R. R. (1987). Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology, 91, 268-272.
25. LeSage, M., Clark, R., & Poling, A. (1993). MDMA and memory: The acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure. Psychopharmacology, 110, 327-332.
26. LeSage, M., & Poling, A. (1997). MDMA and d-amphetamine produce comparable effects in pigeons performing under a multiple fixed-ratio interresponse-time-greater-than-t schedule of food delivery. Pharmacology Biochemistry and Behavior, 57, 173-177.
27. Leshner, A. (2001, December). Using science to counter the spread of ecstasy abuse. NIDA Notes, 16, 3-4.
28. Li, A. A., Marek, G. J., Vosmer, G., & Seiden, L. S. (1989). Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacology Biochemistry and Behavior, 33, 641-648.
29. Macenski, M. J., Schaal, D. W., Cleary, J., & Thompson, T. (1993). Changes in food-maintained progressive-ratio responding following chronic buprenorphine or methadone administration. Pharmacology Biochemistry and Behavior, 47, 379-383.
30. Martinez-Price, D. L., Krebs-Thomson, K., & Geyer, M. A. (2002). Behavioral psychopharmacology of MDMA and MDMA-like drugs: A review of human and animal studies. Addiction Research & Theory, 10, 43-67.
31. McDowell, D. M., & Kleber, H. D. (1994). MDMA: Its history and pharmacology. Psychiatric Annals, 24, 127-130.
32. McKearney, J. W., & Barrett, J. E. (1978). Schedule-controlled behavior and the effects of drugs. In D. E. Blackman & D. J. Sanger (Eds.), Contemporary research in behavioral pharmacology (pp. 1-68). New York: Plenum Press.
33. McKenna, D. J., & Peroutka, S. J. (1990). Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Journal of Neurochemistry, 54, 14-22.
34. Miczek, K. A., & Haney, M. (1994). Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: Aggressive and schedule-controlled behavior in mice. Psychopharmacology, 115, 358-365.
35. Millenson, J. R. (1967). Principles of behavioral analysis. New York: Macmillan.
36. Miller, N. E. (1956). Effects of drugs on motivation: The value of using a variety of measures. Annals of the New York Academy of Sciences, 65, 318-333.
37. Miller, N. E. (1957, December 20). Experiments on motivation: Studies combining psychological, physiological, and pharmacological techniques. Science, 126, 1271-1278.
38. Milroy, C. M., Clark, J. C., & Forrest, A. R. (1996). Pathology of deaths associated with "ecstasy" and "eve" misuse. Journal of Clinical Pathology, 49, 149-153.
39. Nader, M. A., Hoffmann, S. M., & Barrett, J. E. (1989). Behavioral effects of (±)3,4-methylenedioxyamphetamine (MDA) and (±)3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: Interactions with noradrenergic and serotonergic systems. Psychopharmacology, 98, 183-188.
40. Nagilla, R., Newland, M. C., Snyder, J., & Bronson, M. E. (1998). Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats. European Journal of Pharmacology, 358, 1-8.
41. National Research Council, Institute of Laboratory Animal Resources, Commission on Life Sciences. (1996). Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
42. Nichols, D. E. (1986). Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. Journal of Psychoactive Drugs, 18, 305-313.
43. Oberlender, R., & Nichols, D. E. (1988). Drug discrimination studies with MDMA and amphetamine. Psychopharmacology, 95, 71-76.
44. O'Loinsigh, E. D., Boland, G., Kelly, J. P., & O'Boyle, K. M. (2001). Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 25, 621-638.
45. Perone, M. (1991). Experimental design in the analysis of free-operant behavior. In I. H. Iversen & K. A. Lattal (Eds.), Experimental analysis of behavior: Part I (pp. 135-172). Amsterdam: Elsevier.
46. Poling, A., Byrne, T., & Morgan, T. (2000). Stimulus properties of drugs. In A. Poling & T. Byrne (Eds.), Introduction to behavioral pharmacology (pp. 141-166). Reno, NV: Context Press.
47. Poling, A., LeSage, M., Roe, D., & Schaefer, D. (1996). Acute and chronic effects of morphine in pigeons responding under a progressive-ratio schedule of food delivery. Pharmacology Biochemistry and Behavior, 54, 485-490.
48. Rezvani, A. H., Garges, P. L., Miller, D. B., & Gordon, C. J. (1992). Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats. Pharmacology Biochemistry and Behavior, 43, 103-110.
49. Rosencrans, J. A., & Glennon, R. A. (1987). The effect of MDA and MDMA ("ecstasy") isomers in combination with pirenpirone on operant responding in mice. Pharmacology Biochemistry and Behavior, 28, 39-42.
50. Schulze, G. E., & Paule, M. G. (1990). Acute effects of d-amphetamine in a monkey operant test battery. Pharmacology Biochemistry and Behavior, 35, 759-765.
51. Schwartz, R. H., & Miller, N. S. (1997). MDMA (ecstasy) and the rave: A review. Pediatrics, 100, 705-708.
52. Spanos, L. J., & Yamamoto, B. K. (1989). Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacology Biochemistry and Behavior, 32, 835-840.
53. Stafford, D., & Branch, M. N. (1998). Effects of step size and break-point criterion on progressive-ratio performance. Journal of the Experimental Analysis of Behavior, 70, 123-138.
54. Stafford, D., LeSage, M. G., & Glowa, J. R. (1998). Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: A review. Psychopharmacology, 139, 169-184.
55. Stewart, W. N. (1975). Progressive reinforcement schedules: A review and evaluation. Australian Journal of Psychology, 1, 9-22.
56. Thomas, J. R. (1976). Interactions between hyperbaric air and d-amphetamine effects on performance. Psychopharmacology, 48, 69-73.
57. Thompson, D. M. (1972a). Effects of d-amphetamine on the "breakpoint" of progressive-ratio performance. Psychonomic Science, 29, 282-284.
58. Thompson, D. M. (1972b). Enhancement of progressive-ratio performance by chlordiazepoxide and phenobarbital. Journal of the Experimental Analysis of Behavior, 17, 287-292.
59. Thompson, D. M., Winsauer, P. J., & Mastropaolo, J. (1987). Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys. Pharmacology Biochemistry and Behavior, 26, 401-405.